Burning Rock Biotech (BNR) EBITDA Margin (2019 - 2025)
Burning Rock Biotech (BNR) recorded quarterly EBITDA Margin of 13.8% in Q4 2025, up 1.79% quarter-over-quarter from 14.05% in Q3 2025, and up 4594.0% on a YoY basis from 0.29% in Q4 2024.
Burning Rock Biotech (BNR) EBITDA Margin (2019 - 2025) Analysis & Trends
Burning Rock Biotech's EBITDA Margin history runs 7 years deep, the most recent figure standing at 13.8% for Q4 2025.
- In Q4 2025, EBITDA Margin rose 4594.0% year-over-year to 13.8%; the TTM figure through Dec 2025 stood at 11.04% (up 5523.0% YoY), while the FY2025 annual figure was 11.02%, up 5551.0% from the prior year.
- EBITDA Margin was 13.8% for Q4 2025 at Burning Rock Biotech, up from 14.05% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 6.69% in Q2 2025 to a low of 195.13% in Q1 2022.
- Historically, EBITDA Margin has averaged 105.84% across 5 years, with a median of 131.87% in 2021.
- The sharpest annual moves came in 2021 and 2024: EBITDA Margin tumbled 11890 bps in 2021, then soared 10774 bps in 2024.
- A 5-year view of EBITDA Margin shows it stood at 187.22% in 2021, then rose by 17 bps to 156.21% in 2022, then rose by 13 bps to 136.47% in 2023, then surged by 56 bps to 59.74% in 2024, then surged by 77 bps to 13.8% in 2025.
- The last three EBITDA Margin figures came in at 13.8% (Q4 2025), 14.05% (Q3 2025), and 6.69% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 21.74% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -12.21% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 19.42% |
| 10 | Burning Rock Biotech | 20.64 Mn | -47.19 Mn | 14.10 Mn | -13.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.80% |
| Sep 30, 2025 | -14.05% |
| Jun 30, 2025 | -6.69% |
| Mar 31, 2025 | -10.21% |
| Dec 31, 2024 | -59.74% |
| Sep 30, 2024 | -30.95% |
| Jun 30, 2024 | -79.02% |
| Mar 31, 2024 | -96.29% |
| Dec 31, 2023 | -136.47% |
| Sep 30, 2023 | -138.69% |
| Jun 30, 2023 | -79.59% |
| Mar 31, 2023 | -133.96% |
| Dec 31, 2022 | -156.21% |
| Sep 30, 2022 | -136.35% |
| Jun 30, 2022 | -177.65% |
| Mar 31, 2022 | -195.13% |
| Dec 31, 2021 | -187.22% |
| Sep 30, 2021 | -129.79% |
| Jun 30, 2021 | -187.51% |
| Mar 31, 2021 | -147.55% |